ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Neurology

Top Neurology Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
HENRIK WILMS MD

Neurology

158

$19.1K

24
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 28%

$121
Average prescription price

Avg: $218

RIO GRANDE VALLEY NEUROLOGY PA

Neurology

183

$15K

27
20 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 28%

$82
Average prescription price

Avg: $218

MADHURI KOGANTI M.D.

Neurology

190

$23.5K

60
45 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 28%

$124
Average prescription price

Avg: $218

RAJANI CAESAR MD

Neurology

218

$60.8K

36
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 28%

$279
Average prescription price

Avg: $218

NOEL BAKER MD

Neurology

223

$25.5K

30
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 28%

$114
Average prescription price

Avg: $218

SHYAMA SATYAN

Neurology

224

$43.3K

20
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

0%
prescriptions for brand name drugs

Avg: 28%

$193
Average prescription price

Avg: $218

SABINA MIRANDA DO

Neurology

245

$23.9K

50
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 28%

$98
Average prescription price

Avg: $218

MAZEN DIMACHKIE M.D.

Neurology

249

$115K

43
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 28%

$463
Average prescription price

Avg: $218

JENNIFER YORK M.D.

Neurology

256

$41.4K

37
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 28%

$162
Average prescription price

Avg: $218

JOHN NORRIS M.D., PH.D.

Neurology

257

$51.1K

62
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 28%

$199
Average prescription price

Avg: $218

GREGORY CARTER M.D., PH.D.

Neurology

258

$39.4K

51
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 28%

$153
Average prescription price

Avg: $218

STANTON MOLDOVAN M.D.

Neurology

264

$13.6K

54
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

59%
patients receiving schedule three controlled substances

Avg: 5%

20%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 28%

$51
Average prescription price

Avg: $218

MONICA LOGHIN M.D.

Neurology

275

$40.3K

52
32 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 28%

$147
Average prescription price

Avg: $218

EDDIE PATTON M.D.

Neurology

284

$63.2K

78
67 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 28%

$223
Average prescription price

Avg: $218

DAVID ROSENFIELD M.D.

Neurology

289

$34.1K

87
77 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 28%

$118
Average prescription price

Avg: $218

PUNEET GUPTA MD

Neurology

290

$93.8K

39
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 28%

$323
Average prescription price

Avg: $218

EDWARD ESCOBAR DO

Neurology

297

$94.6K

75
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 28%

$318
Average prescription price

Avg: $218

JOHNNIE ROSE M.D.

Neurology

299

$14.2K

39
17 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

6%
prescriptions for brand name drugs

Avg: 28%

$48
Average prescription price

Avg: $218

DIANE SOLOMON M.D.

Neurology

309

$71.1K

44
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 28%

$230
Average prescription price

Avg: $218

PAMELA NEW M.D.

Neurology

328

$28.4K

26
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 28%

$87
Average prescription price

Avg: $218

MAKOTO KAWAI M.D.

Neurology

340

$73.9K

47
20 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 28%

$217
Average prescription price

Avg: $218

BANGARUSWAMY KUMAR MD

Neurology

340

$11.5K

69
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

0%
prescriptions for brand name drugs

Avg: 28%

$34
Average prescription price

Avg: $218

TODD MASEL MD

Neurology

346

$65.4K

66
20 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 28%

$189
Average prescription price

Avg: $218

RANJEETA MANI MD

Neurology

348

$21.3K

103
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 28%

$61
Average prescription price

Avg: $218

KAREN BONTIA M.D.

Neurology

350

$82.2K

108
71 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 28%

$235
Average prescription price

Avg: $218

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank